Codexis, Inc. (CDXS) - Latest Market Data

Price & Market Data

Price: $2.57

Daily Change: -$0.08 / 3.11%

Daily Range: $2.51 - $2.69

Market Cap: $230,877,280

Daily Volume: 938,909

Performance Metrics

1 Week: -7.64%

1 Month: 10.43%

3 Months: 103.2%

6 Months: 50.30%

1 Year: -3.79%

YTD: 55.83%

About Codexis, Inc. (CDXS)

Detailed market data for Codexis, Inc. (CDXS) is now available. Priced at 2.57, the stock has recorded a daily change of -$0.08 / 3.11%. Its market capitalization is 230,877,280. Dive into its performance across all listed timeframes, from short-term fluctuations to long-term growth trends.

Company Details

Employees: 146

Sector: Process industries

Industry: Chemicals: specialty

Country: United States

Details

Codexis, Inc. provides technology solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, enhance, and commercialize novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China. The company develops its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a license agreement with Aldevron LLC and Pfizer Inc. The company was incorporated in 2002 and is headquartered in Redwood City, California.

Selected stocks

ProMIS Neurosciences Inc. (PMN)

Stoke Therapeutics, Inc. (STOK)

NewtekOne, Inc. - Depositary Shares, Each Representing a 1/40th Interest in a Share of 8.500% Fixed Rate Reset Non-Cumulative Perpetual Preferred Stock, Series (NEWTP)

RF Acquisition Corp II (RFAI)

Sow Good Inc. (SOWG)